Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy and Safety of Nano-crystalline Megestrol Acetate for the Prevention of Nausea and Vomiting Caused by Emetogenic Chemotherapy: a Randomized, Controlled, Multicenter Clinical Study

NCT07246070 is registered in ClinicalTrials.gov with AIPING ZHOU as lead sponsor.

NCT NCT07246070
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07246070 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy and Safety of Nano-crystalline Megestrol Acetate for the Prevention of Nausea and Vomiting Caused by Emetogenic Chemotherapy: a Randomized, Controlled, Multicenter Clinical Study
Lead sponsor
AIPING ZHOU
Phase
Phase 2
Overall status
Not yet recruiting
Start date
December 31, 2025
Completion date
December 31, 2026
Enrollment
127 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy-induced nausea and vomiting (cinv)